Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Functional Recovery Program for Depression and Suicide Risk (RECONCILE)

Official title: The SURVIVE 2 Project: An Extended Cohort Study to Investigate Suicidal Behavior in Spain and the Efficacy of Secondary Prevention Strategies: iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)

Run by Hospital Clinic of Barcelona · NCT05655390 · Data updated 2026-11-12

This study tests a 12-week telehealth group program designed to help adults who recently attempted suicide and have depression improve daily functioning, emotion regulation, and cognitive control.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorHospital Clinic of Barcelona
Academic / other
Drugs / interventionsradiation
Locations4 sites (Barcelona, Barcelona and 3 other locations)
StatusRecruiting
StartedSeptember 16, 2025
Main results expectedApril 2027
Study endsOctober 2027
Registry record updatedMay 12, 2026
Trial IDNCT05655390 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with depression who have attempted suicide within the prior 10 days, can give informed consent, have no MRI contraindications, and have not received structured psychological interventions or ECT in the past 6 months are ideal candidates.

Probably not a fit

Patients with IQ below 70, major neurological conditions or recent head trauma, those unable to consent or participate in telematic group sessions, or those who received recent structured psychotherapy or ECT may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

RECONCILE is a multicenter, rater-blinded randomized trial in Spain that randomizes adults with recent suicide attempts to treatment-as-usual (TAU) or TAU plus a 12-week structured telematic group program. The group program delivers 12 weekly 90-minute sessions led by two trained therapists and combines Acceptance and Commitment Therapy with elements of CBT, DBT, psychoeducation, and an individualized safety plan. Outcomes include psychosocial functioning, cognition (decision-making, inhibition, attention), quality of life, clinical status, and neuroimaging correlates focused on the orbitofrontal and dorsal prefrontal cortices, with assessments at baseline, post-intervention, and 12-month follow-up. The study also enrolls comparison cohorts of depressed patients without recent attempts and healthy controls at one site to contextualize findings.

Why it matters

Potential benefit: If successful, the program could improve patients' ability to perform daily activities and reduce ongoing suicide risk by strengthening emotion regulation and functional skills.

How similar studies have gone: Therapies that include ACT and DBT components have shown benefits for suicidal behavior and emotion regulation, but this particular combined telematic group program targeting early post-attempt functional recovery is relatively novel and not extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 18 years old
* Having attempted suicide
* Provide written informed consent
* No claustrophobia/metallic objects/implants

Exclusion Criteria:

* Intelligence quotient below 70 and impaired functioning
* Any medical condition that could affect neuropsychological performance (such as neurological diseases) or a history of head trauma with loss of consciousness
* Participation in any structured psychological intervention within the past 6 months
* Patients who received electroconvulsive therapy within the past 6 months
* Inability to give inform consent

Where it's running

  • Hospital Clínic Barcelona
    Barcelona, Barcelona, Spain
    Recruiting
  • Hospital del Mar
    Barcelona, Spain
    Recruiting
  • Hospital Clínico San Carlos
    Madrid, Spain
    Recruiting
  • Hospital Gregorio Marañón
    Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Iria Grande — IDIBAPS- Hospital Clinic de Barcelona
  • Study coordinator: Iria Grande
  • Email: igrande@clinic.cat
  • Phone: +34932275400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.